LABA/LAMA (Pulmatrix)

N/A

Report date: 2025/11/27 14:08:05
NME

Base Information

Drug NameLABA/LAMA (Pulmatrix)
Drug Alias NameIS-103
ClassificationSmall molecules > Steroids
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes LABA (Pulmatrix)LAMA (Pulmatrix)
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPulmatrix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPulmatrix Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A